Bölüm "İstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü" Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed için listeleme
Toplam kayıt 6, listelenen: 1-6
-
Evlat edindim, emzirmek istiyorum: Olgu sunumu
(2020)Anne sütü ile beslenmenin bebek ve anne sağlığı üzerine pek çok olumlu etkisi olduğu bilinmektedir. Annelerin bebeği için en iyisini istemesi dışında emzirmenin toplumda anne kimliğini sembolize etmesi de anneleri emzirmeye ... -
Higher rates of COVID-19 but less severe infections reported for patients on dupilumab: A big data analysis of the world health organization vigibase
(Verduci Editore s.r.l, 2021)Objective: Dupilumab (Dupixent ®) is a monoclonal antibody that inhibits IL- 4 and IL-13 signaling used for the treatment of allergic diseases. Whilst biologic therapy is traditionally regarded as immunosuppressive and ... -
Investigating the roles of micrornas / lncrnas in characterizing breast cancer subtypes and prognosis
(2023)Molecular subtyping is a method of separating tumor clusters in a cancer type with common features according to molecular data and classification models. Genome datasets are taken from many different people and some genetic ... -
Knowing the ABCs: Teaching the principles of radiology to medical students in Turkey
(BioMed Central Ltd, 2022)Background: Radiology education in Turkey is mainly taught during clinical years of medical school and often lacks main principles. Exposure to the fundamentals of radiology at an early stage of medical education may ... -
KoExPubMed: A tool for effective and customized knowledge extraction from PubMed
(2023)An exponential growth in the literature in general and the medical literature in particular raises a need for effective intelligent analysis strategies and tools to provide valuable insights to researchers about the current ... -
Systematic review and meta-analysis of tocilizumab therapy versus standard of care in over 15,000 COVID-19 pneumonia patients during the first eight months of the pandemic
(MDPI, 2021)Background. Tocilizumab is an anti-IL-6 therapy widely adopted in the management of the so-called "cytokine storm" related to SARS-CoV-2 virus infection, but its effectiveness, use in relation to concomitant corticosteroid ...